Matthias Guckenberger

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Matthias Guckenberger
Jan 11, 2025, 08:55 | Blog
Matthias Guckenberger: Early registration deadline is approaching for ESTRO25
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: "ESTRO25 in Vienna is…
Jan 2, 2025, 19:46 | Insight
Matthias Guckenberger: Aiming to refine your radiation oncology in 2025?
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Aiming to refine your…
Dec 27, 2024, 17:00 | Science
Corinne Faivre-Finn: An International EORTC Survey on Stage III NSCLC resectability
Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at the University of Manchester, posted on X…
Dec 26, 2024, 13:24 | Insight
Matthias Guckenberger: Virtual Grand Rounds in Radiation Oncology with Alberto Bossi
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Virtual Grand Rounds in…
Dec 21, 2024, 18:35 | Science
Randomized comparison of SBRT vs RFA for recurrent small HCC
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared a recent article by Mian Xi…
Dec 17, 2024, 06:38 | Blog
Matthias Guckenberger: What modern radiotherapy can achieve for elderly breast cancer patients
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Remember the misleading press…
Nov 15, 2024, 20:28 | Blog
Long-Term Adverse Effects and Complications After Prostate Cancer Treatment
A recent paper by Joseph Unger, Associate Professor at Fred Hutchinson Cancer Center, was mentioned by…
Nov 2, 2024, 03:18 | Blog
Matthias Guckenberger: Is SBRT the New Standard of Care for Prostate Cancer?
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, posted the following on X: “SBRT for localized prostate…
Oct 22, 2024, 16:29 | Blog
Matthias Guckenberger: Honored to represent ESTRO at international meetings
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, posted the following on LinkedIn: “Exciting weeks have…
Oct 12, 2024, 19:22 | Insight
Session on the multidisciplinary approach to cancer treatment at the EORTC Patient Days
EORTC - European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:…
Sep 13, 2024, 18:54 | Blog
Zulema Altamirano to speak on Gender Equality at ESMO24 W4O Forum
ESMO – European Society for Medical Oncology posted the following on LinkedIn: “Zulema Altamirano, Ph.D,…
Sep 11, 2024, 06:51 | Blog
Fabio Moraes: WCLC24 is around the corner and looks great
Fabio Moraes shared on X: "Exciting week - WCLC24 is around the corner and looks…
Aug 27, 2024, 21:39 | Blog
Applying multidisciplinary tumor board recommendations in management of oligometastatic cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X…
Aug 11, 2024, 14:31 | Blog
Nermean Mostafa: Looking forward for a rocking session in ESMO24
Nermean Mostafa, Head of Clinical Oncology unit at Ain shams University, shared a post on…
Aug 11, 2024, 12:42 | Blog
"Empowering women in oncology" - ESMO24 Women For Oncology Forum
ESMO posted on LinkedIn: "ESMOW4O: Join the ESMO Women For Oncology Forum at ESMO24 entitled 'Empowering…
Jul 13, 2024, 14:28 | Blog
Matthias Guckenberger: Virtual Grand Rounds in Radiation Oncology
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: "THE highlight before summer break…
Jun 22, 2024, 11:24 | Blog
Neoadjuvant immunotherapy and SBRT in HCC
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared a post on X: "Neoadjuvant immunotherapy and…
Jun 18, 2024, 18:23 | Insight
Matthias Guckenberger: Cancer trial participation not associated with longer OS compared to routine care
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X: “Cancer trial participation not…
May 25, 2024, 06:44 | Insight
The third cohort of the Certificate of Advanced Studies in Lung Cancer - European School of Oncology
European School of Oncology shared on LinkedIn: “The third cohort of the Certificate of Advanced…
May 11, 2024, 13:18 | Career
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn: "We're thrilled to announce the…
Apr 29, 2024, 15:33 | Blog
Lucjan Wyrwicz: European perspective of OMEC-4 survey
Lucjan Wyrwicz, Medical Oncologist at Maria Curie National Cancer Research Institute in Warsaw, Poland, recently…
Mar 28, 2024, 19:34 | Societies
Cecilia Pompili: Personalized care in lung cancer will not be possible without multidisciplinary team and collaboration between specialities as we have seen during ELCC24
Mar 25, 2024, 15:15 | Societies
25 Posts Not To Miss From ELCC 2024
The European Lung Cancer Congress (ELCC 2024) took place in Prague, Czech Republic, from 20th…
Feb 13, 2024, 18:54 | Opinion
Jill Feldman: It's the era of patient-centered ‘everything’ and patients are the ONLY ones who can define what that means
Jill Feldman shared Fumiko Ladd Chino's post on X/Twitter, adding: "It's the era of patient-centered ‘everything’…
Oct 31, 2023, 09:57 | Blog
Matthias Guckenberger: Virtual Grand Rounds in Radiation Oncology
Matthias Guckenberger, Radiation Oncologist at University Hospital Zurich, shared on X/Twitter: "Approaching quickly: Virtual Grand…
Oct 7, 2023, 17:20 | Blog
15 posts from ASTRO23 not to miss.
The 65th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2023) took place at…
Aug 19, 2023, 19:07 | Insight
Matthias Guckenberger: First esophageal cancer patient enrolled into randomized protect trial.
Matthias Guckenberger, the Chairman and a Professor of the Department of Radiation Oncology at the…
All: 27 Posts: 1 - 100
Special Coverage